HEIDELBERG, Germany — This is the initial Europe Regional Medical Command H1N1 update. Periodic updates will include information about vaccine arrival, distribution, eligibility and vaccination schedules.
- Vaccine expected in Europe early November 2009 in stages and availability will be widely publicized.
- Supplies may not be available all at once. Call your clinic to check.
There are two separate types of vaccine, one is earmarked for non-uniformed beneficiaries and the other is for uniformed personnel. Vaccine for non-uniformed beneficiaries is an inactivated, injectable vaccine that ismanufactured by Sanofi-Pasteur, it is approved for ages 6 months and older. These vaccination target groups have equal priority: - Pregnant women - Beneficiaries 6 months-24 years old - Caregivers/families of babies less than 6 months old - People 25-64 years old with medical conditions that put them more at risk - Children 6 months to 9 years old will need to get two doses, separated by 4 weeks, to fully protect them - Vaccine will be given to all TRICARE beneficiaries and DoD employees
Vaccine for uniformed beneficiaries is an inactivated, injectable vaccine manufactured by Novartis. Priority is deployed or deploying service members, direct healthcare providers, then all other active duty and 7th CSC Reservists. Novartis and Sanofi-Pasteur are licensed suppliers of seasonal influenza vaccines, and use the same manufacturing processes and quality testing procedures for H1N1 vaccine.
Hand hygiene/respiratory etiquette is key for prevention.